Piper Sandler raised the firm’s price target on Skyward Specialty Insurance to $48 from $46 and keeps an Overweight rating on the shares. The firm cites a beat driven primarily by a combination of better-than-expected net investment income and underwriting results. Skyward appears to have avoided problems this quarter related to investor concerns that the specialty commercial insurance business is becoming more competitive, Piper adds.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SKWD:
- Skyward Specialty Insurance price target raised to $50 from $47 at JMP Securities
- Is SKWD a Buy, Before Earnings?
- Skyward Specialty Achieves “A” (Excellent) Rating Upgrade by AM Best
- Skyward Specialty Recruits Julie Miglin to Lead New Life Sciences Unit and Steven Smith to Lead Transactional E&S Property Portfolio
- Skyward Specialty Insurance initiated with a Perform at Oppenheimer